NCT05018481View on ClinicalTrials.gov

HA35 Moderate Alcoholic Hepatitis (AH) Study

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

September 1, 2022

Primary Completion Date

October 1, 2025

Study Completion Date

October 1, 2026

Conditions
Alcoholic Hepatitis
Interventions
DRUG

Sodium Hyaluronate

Sodium hyaluronate of molecular weight 35kDa will be given in capsule form to study participants

DRUG

Placebo

A placebo will be given in capsule form to study participants

Trial Locations (1)

44195

RECRUITING

Cleveland Clinic, Cleveland

All Listed Sponsors
lead

The Cleveland Clinic

OTHER